nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—CCR1—cardiovascular system—metabolic syndrome X	0.0417	0.317	CbGeAlD
Raltegravir—CCR1—adipose tissue—metabolic syndrome X	0.0368	0.279	CbGeAlD
Raltegravir—Epigastric discomfort—Metformin—metabolic syndrome X	0.028	0.0606	CcSEcCtD
Raltegravir—CCR1—liver—metabolic syndrome X	0.0258	0.196	CbGeAlD
Raltegravir—CCR1—Chemokine receptors bind chemokines—CCL5—metabolic syndrome X	0.0242	0.0595	CbGpPWpGaD
Raltegravir—UGT1A1—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.0187	0.0461	CbGpPWpGaD
Raltegravir—UGT1A1—kidney—metabolic syndrome X	0.0168	0.127	CbGeAlD
Raltegravir—CCR1—Chemokine receptors bind chemokines—CCL2—metabolic syndrome X	0.0167	0.041	CbGpPWpGaD
Raltegravir—Chest discomfort—Metformin—metabolic syndrome X	0.0166	0.036	CcSEcCtD
Raltegravir—CCR1—G alpha (i) signalling events—MTNR1B—metabolic syndrome X	0.0142	0.0349	CbGpPWpGaD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	0.0132	0.0324	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—GHRL—metabolic syndrome X	0.0124	0.0305	CbGpPWpGaD
Raltegravir—Nasal congestion—Metformin—metabolic syndrome X	0.0117	0.0254	CcSEcCtD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.0113	0.0277	CbGpPWpGaD
Raltegravir—Renal impairment—Metformin—metabolic syndrome X	0.0112	0.0243	CcSEcCtD
Raltegravir—Lethargy—Metformin—metabolic syndrome X	0.0109	0.0236	CcSEcCtD
Raltegravir—Pain in extremity—Metformin—metabolic syndrome X	0.0107	0.0231	CcSEcCtD
Raltegravir—UGT1A1—liver—metabolic syndrome X	0.0106	0.0805	CbGeAlD
Raltegravir—Migraine—Metformin—metabolic syndrome X	0.0105	0.0228	CcSEcCtD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.0103	0.0252	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—CNR1—metabolic syndrome X	0.00992	0.0244	CbGpPWpGaD
Raltegravir—Abdominal pain upper—Metformin—metabolic syndrome X	0.00974	0.0211	CcSEcCtD
Raltegravir—Breast disorder—Metformin—metabolic syndrome X	0.00964	0.0209	CcSEcCtD
Raltegravir—Nasopharyngitis—Metformin—metabolic syndrome X	0.00954	0.0207	CcSEcCtD
Raltegravir—Abdominal distension—Metformin—metabolic syndrome X	0.00928	0.0201	CcSEcCtD
Raltegravir—Influenza—Metformin—metabolic syndrome X	0.00922	0.02	CcSEcCtD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.00921	0.0226	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—CCL5—metabolic syndrome X	0.00911	0.0224	CbGpPWpGaD
Raltegravir—Abdominal discomfort—Metformin—metabolic syndrome X	0.00884	0.0192	CcSEcCtD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.00879	0.0216	CbGpPWpGaD
Raltegravir—Neutropenia—Metformin—metabolic syndrome X	0.00862	0.0187	CcSEcCtD
Raltegravir—CCR1—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.00859	0.0211	CbGpPWpGaD
Raltegravir—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00857	0.0186	CcSEcCtD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.00833	0.0205	CbGpPWpGaD
Raltegravir—Infestation—Metformin—metabolic syndrome X	0.00822	0.0178	CcSEcCtD
Raltegravir—Infestation NOS—Metformin—metabolic syndrome X	0.00822	0.0178	CcSEcCtD
Raltegravir—Neuropathy peripheral—Metformin—metabolic syndrome X	0.00806	0.0175	CcSEcCtD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.00789	0.0194	CbGpPWpGaD
Raltegravir—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00778	0.0169	CcSEcCtD
Raltegravir—CCR1—G alpha (i) signalling events—CCL5—metabolic syndrome X	0.00769	0.0189	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—AGT—metabolic syndrome X	0.00762	0.0187	CbGpPWpGaD
Raltegravir—Hepatitis—Metformin—metabolic syndrome X	0.00738	0.016	CcSEcCtD
Raltegravir—Hypoaesthesia—Metformin—metabolic syndrome X	0.00734	0.0159	CcSEcCtD
Raltegravir—Oedema peripheral—Metformin—metabolic syndrome X	0.00727	0.0158	CcSEcCtD
Raltegravir—Connective tissue disorder—Metformin—metabolic syndrome X	0.00725	0.0157	CcSEcCtD
Raltegravir—UGT1A1—Biological oxidations—FMO3—metabolic syndrome X	0.00723	0.0178	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—FMO3—metabolic syndrome X	0.00713	0.0175	CbGpPWpGaD
Raltegravir—Eye disorder—Metformin—metabolic syndrome X	0.0069	0.0149	CcSEcCtD
Raltegravir—Cardiac disorder—Metformin—metabolic syndrome X	0.00685	0.0148	CcSEcCtD
Raltegravir—Angiopathy—Metformin—metabolic syndrome X	0.0067	0.0145	CcSEcCtD
Raltegravir—CCR1—GPCR ligand binding—HTR2C—metabolic syndrome X	0.00669	0.0164	CbGpPWpGaD
Raltegravir—Immune system disorder—Metformin—metabolic syndrome X	0.00667	0.0144	CcSEcCtD
Raltegravir—Mediastinal disorder—Metformin—metabolic syndrome X	0.00665	0.0144	CcSEcCtD
Raltegravir—Chills—Metformin—metabolic syndrome X	0.00662	0.0144	CcSEcCtD
Raltegravir—CCR1—G alpha (i) signalling events—AGT—metabolic syndrome X	0.00643	0.0158	CbGpPWpGaD
Raltegravir—Malnutrition—Metformin—metabolic syndrome X	0.00643	0.0139	CcSEcCtD
Raltegravir—Erythema—Metformin—metabolic syndrome X	0.00643	0.0139	CcSEcCtD
Raltegravir—UGT1A1—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.00635	0.0156	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—GHRL—metabolic syndrome X	0.00634	0.0156	CbGpPWpGaD
Raltegravir—Flatulence—Metformin—metabolic syndrome X	0.00633	0.0137	CcSEcCtD
Raltegravir—Dysgeusia—Metformin—metabolic syndrome X	0.00629	0.0136	CcSEcCtD
Raltegravir—CCR1—Peptide ligand-binding receptors—CCL2—metabolic syndrome X	0.00628	0.0154	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.00611	0.015	CbGpPWpGaD
Raltegravir—Tremor—Metformin—metabolic syndrome X	0.00602	0.013	CcSEcCtD
Raltegravir—CCR1—GPCR ligand binding—CNR1—metabolic syndrome X	0.00601	0.0148	CbGpPWpGaD
Raltegravir—Ill-defined disorder—Metformin—metabolic syndrome X	0.00596	0.0129	CcSEcCtD
Raltegravir—Malaise—Metformin—metabolic syndrome X	0.00579	0.0126	CcSEcCtD
Raltegravir—Palpitations—Metformin—metabolic syndrome X	0.00568	0.0123	CcSEcCtD
Raltegravir—Hypertension—Metformin—metabolic syndrome X	0.00555	0.012	CcSEcCtD
Raltegravir—Myalgia—Metformin—metabolic syndrome X	0.00547	0.0119	CcSEcCtD
Raltegravir—Chest pain—Metformin—metabolic syndrome X	0.00547	0.0119	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00543	0.0118	CcSEcCtD
Raltegravir—Discomfort—Metformin—metabolic syndrome X	0.0054	0.0117	CcSEcCtD
Raltegravir—Infection—Metformin—metabolic syndrome X	0.00521	0.0113	CcSEcCtD
Raltegravir—Nervous system disorder—Metformin—metabolic syndrome X	0.00514	0.0111	CcSEcCtD
Raltegravir—Thrombocytopenia—Metformin—metabolic syndrome X	0.00513	0.0111	CcSEcCtD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00511	0.0126	CbGpPWpGaD
Raltegravir—Skin disorder—Metformin—metabolic syndrome X	0.00509	0.011	CcSEcCtD
Raltegravir—Hyperhidrosis—Metformin—metabolic syndrome X	0.00507	0.011	CcSEcCtD
Raltegravir—UGT1A1—NRF2 pathway—G6PD—metabolic syndrome X	0.00496	0.0122	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00485	0.0119	CbGpPWpGaD
Raltegravir—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00478	0.0104	CcSEcCtD
Raltegravir—Paraesthesia—Metformin—metabolic syndrome X	0.00471	0.0102	CcSEcCtD
Raltegravir—Somnolence—Metformin—metabolic syndrome X	0.00466	0.0101	CcSEcCtD
Raltegravir—CCR1—GPCR ligand binding—CCL5—metabolic syndrome X	0.00466	0.0114	CbGpPWpGaD
Raltegravir—Dyspepsia—Metformin—metabolic syndrome X	0.00462	0.01	CcSEcCtD
Raltegravir—Decreased appetite—Metformin—metabolic syndrome X	0.00456	0.00988	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00453	0.00981	CcSEcCtD
Raltegravir—Fatigue—Metformin—metabolic syndrome X	0.00452	0.0098	CcSEcCtD
Raltegravir—Constipation—Metformin—metabolic syndrome X	0.00448	0.00972	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00441	0.0108	CbGpPWpGaD
Raltegravir—Feeling abnormal—Metformin—metabolic syndrome X	0.00432	0.00936	CcSEcCtD
Raltegravir—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00429	0.00929	CcSEcCtD
Raltegravir—UGT1A1—Phase II conjugation—GGT1—metabolic syndrome X	0.00424	0.0104	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.00421	0.0104	CbGpPWpGaD
Raltegravir—Urticaria—Metformin—metabolic syndrome X	0.00417	0.00903	CcSEcCtD
Raltegravir—Abdominal pain—Metformin—metabolic syndrome X	0.00415	0.00898	CcSEcCtD
Raltegravir—CCR1—GPCR ligand binding—AGT—metabolic syndrome X	0.00389	0.00957	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00378	0.00929	CbGpPWpGaD
Raltegravir—Asthenia—Metformin—metabolic syndrome X	0.00376	0.00815	CcSEcCtD
Raltegravir—Pruritus—Metformin—metabolic syndrome X	0.00371	0.00804	CcSEcCtD
Raltegravir—Diarrhoea—Metformin—metabolic syndrome X	0.00359	0.00777	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00358	0.00881	CbGpPWpGaD
Raltegravir—Dizziness—Metformin—metabolic syndrome X	0.00347	0.00751	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00343	0.00844	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00339	0.00834	CbGpPWpGaD
Raltegravir—Vomiting—Metformin—metabolic syndrome X	0.00333	0.00722	CcSEcCtD
Raltegravir—Rash—Metformin—metabolic syndrome X	0.00331	0.00716	CcSEcCtD
Raltegravir—Dermatitis—Metformin—metabolic syndrome X	0.0033	0.00716	CcSEcCtD
Raltegravir—Headache—Metformin—metabolic syndrome X	0.00329	0.00712	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—GHRL—metabolic syndrome X	0.00325	0.008	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CCL2—metabolic syndrome X	0.00321	0.00788	CbGpPWpGaD
Raltegravir—Nausea—Metformin—metabolic syndrome X	0.00311	0.00675	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—CNR1—metabolic syndrome X	0.00308	0.00758	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—SLC2A4—metabolic syndrome X	0.00292	0.00718	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—HDAC3—metabolic syndrome X	0.00291	0.00716	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—GGT1—metabolic syndrome X	0.00283	0.00696	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00263	0.00647	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MTNR1B—metabolic syndrome X	0.0026	0.0064	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TRIB3—metabolic syndrome X	0.00254	0.00624	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—RBP4—metabolic syndrome X	0.00254	0.00624	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—GGT1—metabolic syndrome X	0.00248	0.0061	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—metabolic syndrome X	0.0024	0.0059	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCL5—metabolic syndrome X	0.00239	0.00587	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00238	0.00585	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—APOC3—metabolic syndrome X	0.00225	0.00552	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—metabolic syndrome X	0.00224	0.00551	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—AGT—metabolic syndrome X	0.0022	0.00541	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—HTR2C—metabolic syndrome X	0.00203	0.00499	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—AGT—metabolic syndrome X	0.002	0.00491	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CYBA—metabolic syndrome X	0.00196	0.00483	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GHRL—metabolic syndrome X	0.00192	0.00473	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CNR1—metabolic syndrome X	0.00182	0.00448	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCL2—metabolic syndrome X	0.00165	0.00405	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IGF2—metabolic syndrome X	0.00149	0.00366	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—APOB—metabolic syndrome X	0.00145	0.00355	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCL5—metabolic syndrome X	0.00141	0.00347	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00141	0.00346	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—LPL—metabolic syndrome X	0.00138	0.00339	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—FMO3—metabolic syndrome X	0.00124	0.00304	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AGT—metabolic syndrome X	0.00118	0.0029	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—APOE—metabolic syndrome X	0.00116	0.00284	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—LEP—metabolic syndrome X	0.00116	0.00284	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—APOA1—metabolic syndrome X	0.00114	0.00281	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—MLXIPL—metabolic syndrome X	0.0011	0.00271	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—EPHX2—metabolic syndrome X	0.0011	0.00271	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—G6PC2—metabolic syndrome X	0.00104	0.00255	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IRS1—metabolic syndrome X	0.00103	0.00254	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—INS—metabolic syndrome X	0.000988	0.00243	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCL2—metabolic syndrome X	0.000972	0.00239	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IGF1—metabolic syndrome X	0.000956	0.00235	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—TGFB1—metabolic syndrome X	0.000952	0.00234	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000908	0.00223	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—FABP4—metabolic syndrome X	0.00088	0.00216	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—NOS3—metabolic syndrome X	0.000867	0.00213	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HSD11B1—metabolic syndrome X	0.000835	0.00205	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—G6PD—metabolic syndrome X	0.000744	0.00183	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000743	0.00183	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL6—metabolic syndrome X	0.000731	0.0018	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HDAC3—metabolic syndrome X	0.000726	0.00178	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LPA—metabolic syndrome X	0.00071	0.00174	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GCKR—metabolic syndrome X	0.00071	0.00174	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PLA2G6—metabolic syndrome X	0.000687	0.00169	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOA5—metabolic syndrome X	0.00068	0.00167	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—AKT1—metabolic syndrome X	0.000674	0.00166	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—TRIB3—metabolic syndrome X	0.000633	0.00155	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TGFB1—metabolic syndrome X	0.000573	0.00141	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—NAMPT—metabolic syndrome X	0.000567	0.00139	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LIPC—metabolic syndrome X	0.000564	0.00139	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GCK—metabolic syndrome X	0.000564	0.00139	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOC3—metabolic syndrome X	0.00056	0.00138	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CETP—metabolic syndrome X	0.000544	0.00134	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SCARB1—metabolic syndrome X	0.000521	0.00128	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SREBF1—metabolic syndrome X	0.000506	0.00124	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GOT2—metabolic syndrome X	0.000492	0.00121	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HMGCR—metabolic syndrome X	0.000492	0.00121	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ABCA1—metabolic syndrome X	0.000438	0.00108	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SLC2A4—metabolic syndrome X	0.000438	0.00108	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IL6—metabolic syndrome X	0.000432	0.00106	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GOT1—metabolic syndrome X	0.000425	0.00104	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GGT1—metabolic syndrome X	0.000425	0.00104	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AKT1—metabolic syndrome X	0.000398	0.000979	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOB—metabolic syndrome X	0.00036	0.000886	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PLA2G4A—metabolic syndrome X	0.000351	0.000862	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LPL—metabolic syndrome X	0.000344	0.000846	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CD36—metabolic syndrome X	0.000327	0.000804	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPARA—metabolic syndrome X	0.000304	0.000747	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—AGT—metabolic syndrome X	0.000294	0.000723	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOE—metabolic syndrome X	0.000288	0.000709	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOA1—metabolic syndrome X	0.000285	0.000701	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPARG—metabolic syndrome X	0.000251	0.000617	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—INS—metabolic syndrome X	0.000246	0.000606	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALB—metabolic syndrome X	0.000226	0.000555	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—NOS3—metabolic syndrome X	0.000216	0.000531	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PTGS2—metabolic syndrome X	0.000198	0.000486	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—AKT1—metabolic syndrome X	9.93e-05	0.000244	CbGpPWpGaD
